About LA CaTS

News

LSU Health Shreveport Promising COVID-19 Clinical Trial

Released: Tuesday, April 14, 2020

LA CaTS Center Research Parter, LSU Health Shreveport, is one of the first centers in the country to enroll patients into an international study testing whether inhaled nitric oxide improves outcomes in COVID-19 patients with lung damage. See links to various news articles below for more information.

Shreveport Times: https://www.shreveporttimes.com/story/news/education/2020/04/06/lsuhs-offering-inhaled-nitric-oxide-clinical-trials-covid-19/2951608001/

WWL.com Newsroom: https://wwl.radio.com/articles/louisiana-radio-network-news/lsu-health-shreveport-testing-to-see-if-inhaled-nitric-oxide

WBRZ: https://www.wbrz.com/news/lsu-health-shreveport-moving-forward-with-promising-clinical-trials-for-covid-19/

 

###

About the Louisiana Clinical and Translational Science (LA CaTS) Center
The LA CaTS Center is comprised of three primary collaborating institutions in the state, including LSU's Pennington Biomedical Research Center in Baton Rouge, LSU Health Sciences Center in New Orleans, and Tulane University School of Medicine in New Orleans – and also includes six research partners: LSU Health Sciences Center in Shreveport, Louisiana State University in Baton Rouge, and in New Orleans, Xavier University of Louisiana, Children’s Hospital, Ochsner Health System, Southeast Louisiana Veterans Health Care System, and University Medical Center.  The LA CaTS Center’s vision for Louisiana encompasses the strengths and capacities unique to each member institution and represents a unified, comprehensive approach for targeting prevention, care and research of chronic diseases in the underserved population.  The scholar program is supported in part by U54 GM104940 from the National Institute of General Medical Sciences of the National Institutes of Health which funds the Louisiana Clinical and Translational Science Center.  For more information, please visit www.lacats.org.